|
| Y/e 31 March 2012 |
Y/e 31 March 2013 |
| Institution |
Last
updated |
EBIT ($m) |
Benchmark
PBT ($m) |
Benchmark
EPS ($c) |
DPS ($c) |
EBIT ($m) |
Benchmark
PBT ($m) |
Benchmark
EPS ($c) |
DPS ($c) |
|---|
| Bank of America Merrill Lynch |
Apr-12 |
1,189 |
1,136 |
80.1 |
32.0 |
1,318 |
1,274 |
89.0 |
35.6 |
|---|
| Citigroup |
Mar-12 |
1,192 |
1,139 |
80.3 |
32.1 |
1,298 |
1,244 |
87.4 |
35.0 |
| Credit Suisse |
Feb-12 |
1,181 |
1,127 |
81.2 |
32.3 |
1,282 |
1,238 |
88.8 |
35.0 |
|---|
| Deutsche Bank |
Jan-12 |
1,190 |
1,129 |
82.9 |
33.1 |
1,290 |
1,231 |
91.2 |
36.5 |
|---|
| Evercore Partners |
Nov-11 |
1,212 |
1,159 |
81.7 |
30.8 |
1,381 |
1,317 |
93.6 |
36.2 |
| Goldman Sachs |
Feb-12 |
1,199 |
1,143 |
83.0 |
33.0 |
1,314 |
1,247 |
92.0 |
37.0 |
|---|
| HSBC |
Jul-11 |
1,220 |
1,165 |
87.6 |
35.0 |
1,395 |
1,337 |
101.3 |
40.5 |
|---|
| Jefferies |
Apr-12 |
1,194 |
1,139 |
81.5 |
32.5 |
1,348 |
1,303 |
92.8 |
37.0 |
|---|
| JP Morgan Cazenove |
Dec-11 |
1,190 |
1,135 |
79.7 |
|
1,286 |
1,226 |
86.5 |
|
|---|
| Morgan Stanley |
Feb-12 |
1,204 |
1,151 |
81.9 |
32.8 |
1,336 |
1,293 |
91.2 |
36.5 |
|---|
| Nomura |
Jan-12 |
1,188 |
1,138 |
79.6 |
33.8 |
1,288 |
1,246 |
86.0 |
38.2 |
|---|
| Oriel Securities |
Feb-12 |
1,185 |
1,133 |
79.0 |
30.8 |
1,335 |
1,284 |
89.6 |
35.3 |
|---|
| RW Baird |
Feb-12 |
1,173 |
1,102 |
80.8 |
32.3 |
1,280 |
1,284 |
91.1 |
36.5 |
|---|
| Seymour Pierce |
Feb-12 |
1,168 |
1,110 |
80.0 |
32.0 |
1,255 |
1,206 |
87.4 |
35.0 |
|---|
| Shore Capital |
Mar-12 |
1,206 |
1,151 |
81.1 |
32.0 |
1,359 |
1,316 |
90.5 |
36.0 |
|---|
| Stephens Inc |
Feb-12 |
1,175 |
1,123 |
80.9 |
29.2 |
1,314 |
1,261 |
90.7 |
39.5 |
|---|
| UBS |
Jan-12 |
1,183 |
1,128 |
80.7 |
32.3 |
1,310 |
1,247 |
89.8 |
35.9 |
|---|
| Total Consensus |
|
1,191 |
1,136 |
81.3 |
32.3 |
1,317 |
1,268 |
90.5 |
36.6 |
|---|
| Max |
|
1,220 |
1,165 |
87.6 |
35.0 |
1,395 |
1,337 |
101.3 |
40.5 |
|---|
| Min |
|
1,168 |
1,102 |
79.0 |
29.2 |
1,255 |
1,206 |
86.0 |
35.0 |
|---|
The forecasts above have been provided to Experian by a number of registered investment analysts for reproduction on Experian's website and as such, the information is publicly available. The information is provided by Experian for information purposes only and is not intended for trading purposes.
The research presented here is the sole responsibility of the registered investment analysts concerned. Experian does not endorse the research in any way and accepts no liability in respect of it. In particular, Experian makes no warranty or representation as to the accuracy of the research, the reasonableness of any assumptions or projections or the likelihood of achieving the figures set out above. Experian has not commented on or verified any individual forecasts, nor does it intend to do so in future. Experian shall not be liable for any errors, inaccuracies or omissions in the content of the information, or for any action taken in reliance thereon.
It should be noted that forecasts are by definition forward looking and are therefore subject to risks and uncertainties that may materially affect eventual results. Experian assumes no obligation to update or revise such information or projections.